Topic
biofungicide
1 stories related to this topic, newest first.
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)finance7 days ago
Biotalys Reports 2025 Financial Results with €8.0 Million Cash Runway and Strategic Refocus
Biotalys announced its consolidated financial results for 2025 on April 29, 2026, showing year-end cash and cash equivalents of €8.0 million, sufficient until the end of May 2026. The company detailed regulatory approvals for its biofungicide EVOCA and progress on pipeline progra…